CD300lf is the primary physiologic receptor of murine norovirus but not human norovirus.

CD300lf is the primary physiologic receptor of murine norovirus but not human norovirus.

Murine norovirus (MNoV) is an important model of human norovirus (HNoV) and mucosal virus infection more broadly. Viral receptor utilization is a major determinant of cell tropism, host range, and pathogenesis. The bona fide receptor for HNoV is unknown. Recently, we identified CD300lf as a proteina...

Full description

Bibliographic Details
Main Authors:	Vincent R Graziano, Forrest C Walker, Elizabeth A Kennedy, Jin Wei, Khalil Ettayebi, Madison S Strine, Renata B Filler, Ebrahim Hassan, Leon L Hsieh, Arthur S Kim, Abimbola O Kolawole, Christiane E Wobus, Lisa C Lindesmith, Ralph S Baric, Mary K Estes, Robert C Orchard, Megan T Baldridge, Craig B Wilen
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2020-04-01
Series:	PLoS Pathogens
Online Access:	https://doi.org/10.1371/journal.ppat.1008242

Similar Items

Norovirus immunity and the great escape.
by: Kari Debbink, et al.
Published: (2012-01-01)

Norovirus Attachment and Entry
by: Vincent R. Graziano, et al.
Published: (2019-05-01)

Recent advances in understanding noroviruses [version 1; referees: 2 approved]
by: Eric Bartnicki, et al.
Published: (2017-01-01)

A Mouse Model for Human Norovirus
by: Stefan Taube, et al.
Published: (2013-08-01)

GII.4 Human Norovirus: Surveying the Antigenic Landscape
by: Michael L. Mallory, et al.
Published: (2019-02-01)

Crossing the T’s on Norovirus
by: Sanghyun Lee, et al.
Published: (2021-01-01)

Norovirus Escape from Broadly Neutralizing Antibodies Is Limited to Allostery-Like Mechanisms
by: Abimbola O. Kolawole, et al.
Published: (2017-10-01)

A working model of how noroviruses infect the intestine.
by: Stephanie M Karst, et al.
Published: (2015-02-01)

Glycolysis Is an Intrinsic Factor for Optimal Replication of a Norovirus
by: Karla D. Passalacqua, et al.
Published: (2019-04-01)

Mechanisms of GII.4 norovirus persistence in human populations.
by: Lisa C Lindesmith, et al.
Published: (2008-02-01)

Structural Studies on the Shapeshifting Murine Norovirus
by: Michael B. Sherman, et al.
Published: (2021-10-01)

Norovirus vaccine induces a cross-genotype protective immune response
by: J. Sherwood, et al.
Published: (2020-12-01)

Immunogenetic mechanisms driving norovirus GII.4 antigenic variation.
by: Lisa C Lindesmith, et al.
Published: (2012-01-01)

Infectious Norovirus Is Chronically Shed by Immunocompromised Pediatric Hosts
by: Amy Davis, et al.
Published: (2020-06-01)

Disruption of the human gut microbiota following Norovirus infection.
by: Adam M Nelson, et al.
Published: (2012-01-01)

Antiviral Activity of Olanexidine-Containing Hand Rub against Human Noroviruses
by: Khalil Ettayebi, et al.
Published: (2022-04-01)

VPg of murine norovirus binds translation initiation factors in infected cells
by: Wobus Christiane E, et al.
Published: (2006-05-01)

Norovírus em alimentos | Norovirus in foods
by: Isabelle da Silva Luz, et al.
Published: (2017-08-01)

Porcine Noroviruses Related to Human Noroviruses
by: Qiu-Hong Wang, et al.
Published: (2005-12-01)

Broadly cross-reactive human antibodies that inhibit genogroup I and II noroviruses
by: Gabriela Alvarado, et al.
Published: (2021-07-01)

norovirus
Published: (2007-03-01)

Human Norovirus Triggers Primary B Cell Immune Activation In Vitro
by: Carmen Mirabelli, et al.
Published: (2022-04-01)

Glycan Recognition in Human Norovirus Infections
by: Victoria R. Tenge, et al.
Published: (2021-10-01)

Emergence of Novel Norovirus GII.4 Variant
by: Preeti Chhabra, et al.
Published: (2024-01-01)

CLIC and membrane wound repair pathways enable pandemic norovirus entry and infection
by: B. Vijayalakshmi Ayyar, et al.
Published: (2023-02-01)

Norovirus Protease Structure and Antivirals Development
by: Boyang Zhao, et al.
Published: (2021-10-01)

Cysteine protease activation and apoptosis in Murine norovirus infection
by: Ettayebi Khalil, et al.
Published: (2009-09-01)

Author Correction: Broadly cross-reactive human antibodies that inhibit genogroup I and II noroviruses
by: Gabriela Alvarado, et al.
Published: (2021-10-01)

Use of Human Intestinal Enteroids to Evaluate Persistence of Infectious Human Norovirus in Seawater
by: Marion Desdouits, et al.
Published: (2022-07-01)

Are Noroviruses Emerging?
by: Marc-Alain Widdowson, et al.
Published: (2005-05-01)

Norovirus evolution in immunodeficient mice reveals potentiated pathogenicity via a single nucleotide change in the viral capsid.
by: Forrest C Walker, et al.
Published: (2021-03-01)

Recombinant norovirus-specific scFv inhibit virus-like particle binding to cellular ligands
by: Hardy Michele E, et al.
Published: (2008-01-01)

Bile Facilitates Human Norovirus Interactions with Diverse Histoblood Group Antigens, Compensating for Capsid Microvariation Observed in 2016–2017 GII.2 Strains
by: Michael L. Mallory, et al.
Published: (2020-09-01)

Immune Imprinting Drives Human Norovirus Potential for Global Spread
by: Lisa C. Lindesmith, et al.
Published: (2022-10-01)

Norovirus Infection in Young Nicaraguan Children Induces Durable and Genotype-Specific Antibody Immunity
by: Paul D. Brewer-Jensen, et al.
Published: (2022-09-01)

Prevalence of human norovirus and Clostridium difficile coinfections in adult hospitalized patients
by: Stokely JN, et al.
Published: (2016-06-01)

Aerosol Transmission of Norovirus
by: Mengdi Tan, et al.
Published: (2024-01-01)

Norovírus em alimentos
by: Isabelle da Silva Luz, et al.
Published: (2017-08-01)

Noroviruses in Archival Samples
by: Sylvain Skraber, et al.
Published: (2005-03-01)

Norovírus em alimentos
by: Isabelle da Silva Luz, et al.
Published: (2017-08-01)